Cite
Biemans VB, Verstockt B. Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European Gastroenterol J. 2020;8(7):753-754doi: 10.1177/2050640620942641.
Biemans, V. B., & Verstockt, B. (2020). Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European gastroenterology journal, 8(7), 753-754. https://doi.org/10.1177/2050640620942641
Biemans, Vince Bc, and Verstockt, Bram. "Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?." United European gastroenterology journal vol. 8,7 (2020): 753-754. doi: https://doi.org/10.1177/2050640620942641
Biemans VB, Verstockt B. Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?. United European Gastroenterol J. 2020 Aug;8(7):753-754. doi: 10.1177/2050640620942641. Epub 2020 Jul 08. PMID: 32640933; PMCID: PMC7434994.
Copy
Download .nbib